Evidence-Based Medicine Guidelines
Aspirin or anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome
Aspirin or anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aspirin or Anticoagulants for the Treatment of Recurrent Pregnancy Loss in Women Without Antiphospholipid Syndrome." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456276/all/Aspirin_or_anticoagulants_for_the_treatment_of_recurrent_pregnancy_loss_in_women_without_antiphospholipid_syndrome.
Aspirin or anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456276/all/Aspirin_or_anticoagulants_for_the_treatment_of_recurrent_pregnancy_loss_in_women_without_antiphospholipid_syndrome. Accessed March 26, 2023.
Aspirin or anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456276/all/Aspirin_or_anticoagulants_for_the_treatment_of_recurrent_pregnancy_loss_in_women_without_antiphospholipid_syndrome
Aspirin or Anticoagulants for the Treatment of Recurrent Pregnancy Loss in Women Without Antiphospholipid Syndrome [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456276/all/Aspirin_or_anticoagulants_for_the_treatment_of_recurrent_pregnancy_loss_in_women_without_antiphospholipid_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aspirin or anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome
ID - 456276
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456276/all/Aspirin_or_anticoagulants_for_the_treatment_of_recurrent_pregnancy_loss_in_women_without_antiphospholipid_syndrome
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
